The pharmaceutical industry has encountered previously unheard-of difficulties in recent years. The average cost of pharmaceuticals in the United States has increased by 24% over the past three years as a result of safety concerns, problems with certain prescriptions, and competition from both non-generic and generic medicines. For individuals with private insurance, this led to a 4% decrease in prescription costs between 2010 and 2013.Developing countries with similar challenges include China, India, and Brazil. One such intervention is developing a series of vaccinations having therapeutic properties.Antibiotics are necessary to treat bacterial infections and preserve population and individual health over the long run. On the other hand, antibiotic-resistant bacterial infections are a global health concern.